<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Genentech Inc.</title><link href="http://infoaboutlungcancer.com/topic/genentech-inc" rel="alternate"></link><id>http://infoaboutlungcancer.com/topic/genentech-inc</id><updated>2010-10-23T16:02:28Z</updated><entry><title>Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival as a First-Line Maintenance Therapy for Advanced Non-Small Cell Lung Cancer</title><link href="http://infoaboutlungcancer.com/phase-iii-study-saturn-showed-tarceva-improved-progressionfree-survival-firstline-maintenance-therapy-advanced-nonsmall-cell-lung-cancer-2950187a" rel="alternate"></link><updated>2010-10-23T16:02:28Z</updated><author><name>Drugs.com</name></author><id>tag:infoaboutlungcancer.com,2010-10-23:/phase-iii-study-saturn-showed-tarceva-improved-progressionfree-survival-firstline-maintenance-therapy-advanced-nonsmall-cell-lung-cancer-2950187a/</id><summary type="html">...</summary><category term="Cancer"></category><category term="Lung Cancer"></category><category term="Pancreatic Cancer"></category><category term="Clinical Trials"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="U.S. Securities and Exchange Commission"></category><category term="California"></category><category term="Italy"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Genentech Inc."></category><category term="Tarceva"></category><category term="American Cancer Society"></category><category term="Milan"></category><category term="South San Francisco"></category><category term="OSI Pharmaceuticals Inc."></category><category term="Southern Europe"></category><category term="Hal Barron"></category><category term="Gabriel Leung"></category><category term="Chemotherapy"></category><category term="New York Stock Exchange"></category></entry><entry><title>Genentech HQ In San Francisco</title><link href="http://infoaboutlungcancer.com/photo/genentech-hq-san-francisco-420560p" rel="alternate"></link><updated>2010-04-15T17:54:12Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:infoaboutlungcancer.com,2010-04-15:/photo/genentech-hq-san-francisco-420560p/</id><summary type="html">Mar 31, 2009 - &lt;a title="San Francisco" href="/topic/San+Francisco" &gt;San Francisco&lt;/a&gt;, &lt;a title="California" href="/topic/California" &gt;California&lt;/a&gt;, &lt;a title="United States" href="/topic/United+States" &gt;USA&lt;/a&gt; - Worldwide HQ of &lt;a title="Genentech Inc." href="/topic/Genentech+Inc." &gt;Genentech&lt;/a&gt; located at 1 DNA Way, South San Francisco. Considered the founder of the biotechnology industry, Genentech uses human genetic information to discover, develop, manufacture, and commercialize medicin...</summary><category term="Company Activities and Information"></category><category term="Mergers and Acquisitions"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="California"></category><category term="San Francisco"></category><category term="Genentech Inc."></category></entry><entry><title>Switzerland Roche Genentech</title><link href="http://infoaboutlungcancer.com/photo/switzerland-roche-genentech-242381p" rel="alternate"></link><updated>2010-04-17T18:14:09Z</updated><author><name>AP News</name></author><id>tag:infoaboutlungcancer.com,2010-04-17:/photo/switzerland-roche-genentech-242381p/</id><summary type="html">&lt;a title="Genentech Inc." href="/topic/Genentech+Inc." &gt;Genentech&lt;/a&gt; headquarters in &lt;a title="South San Francisco" href="/topic/South+San+Francisco" &gt;South San Francisco&lt;/a&gt;, &lt;a title="California" href="/topic/California" &gt;Calif.&lt;/a&gt; seen Friday, March 6, 2009. Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its &lt;a title="United States" href="/topic/United+States" ...</summary><category term="Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="California"></category><category term="Genentech Inc."></category><category term="South San Francisco"></category><category term="Chemotherapy"></category></entry></feed>
